Fortrea

Fortrea Holdings Inc. is a prominent American contract research organization (CRO) based in Durham, North Carolina, with a global presence. The company specializes in biopharmaceutical product and medical device development solutions for clients in the pharmaceutical, biotechnology, and medical device sectors. Fortrea provides a wide array of clinical services, including phase I through IV clinical trial management, clinical pharmacology, and consulting services. Their flexible delivery models cater to diverse client needs, supporting both full-service and hybrid approaches. Founded in 1996 and spun off as an independent entity in 2023, Fortrea has a rich history of innovation in the CRO industry. The company has expanded through strategic acquisitions, enhancing its capabilities in areas such as cell and gene therapy, mobile nursing, and digital clinical trials. Fortrea's clinical research units are staffed by medically trained professionals who prioritize participant safety and engagement in clinical trials, contributing to the development of many leading drugs. The company is dedicated to raising CRO standards and accelerating the delivery of life-changing treatments to patients.